Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.

Authors :: Luszczak S
Simpson BS
Stopka-Farooqui U
Sathyadevan VK
Echeverria LMC
Kumar C
Costa H
Haider A
Freeman A
Jameson C
Ratynska M
Ben-Salha I
Sridhar A
Shaw G
Kelly JD
Pye H
Gately KA
Whitaker HC
Heavey S
Source :: Scientific reports [Sci Rep] 2020 Nov 11; Vol. 10 (1), pp. 19870. Date of Electronic Publication: 2020 Nov 11.
Publication Year :: 2020
Abstract: An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Full Text Access

Tools